Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Reneo Pharmaceuticals, Inc. - Class A Common Stock (NQ:RPHM)

1.820 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	1.820
Bid (Size)	1.820 (1)
Ask (Size)	1.870 (91)
Prev. Close	1.820
Today's Range	1.820 - 1.820
52wk Range	1.250 - 1.820
Shares Outstanding	33,655,123
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million

October 04, 2024

From Reneo Pharmaceuticals, Inc.; OnKure Therapeutics, Inc.

Via GlobeNewswire

Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure

October 02, 2024

From Reneo Pharmaceuticals, Inc.

Via GlobeNewswire

Performance

YTD	N/A	N/A
1 Month	N/A	N/A
3 Month	N/A	N/A
6 Month	N/A	N/A
1 Year	+22.1%	+22.1%

More News

Reneo Pharmaceuticals And 2 Other Stocks Under $5 Executives Are Buying

September 17, 2024

Via Benzinga

RPHM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Reneo Pharmaceuticals, Inc. Is Fair to Shareholders

September 03, 2024

From Halper Sadeh LLC

Via Business Wire

RENEO PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHM

August 29, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

Citizens And 2 Other Penny Stocks Insiders Are Buying

August 15, 2024

Via Benzinga

RPHM Stock Earnings: Reneo Pharmaceuticals Misses EPS for Q2 2024

August 13, 2024

Via InvestorPlace

Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results

August 13, 2024

From Reneo Pharmaceuticals, Inc.

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, SBOW, AGR, RPHM on Behalf of Shareholders

June 25, 2024

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR), SilverBow Resources, Inc. (NYSE - SBOW), Reneo Pharmaceuticals, Inc. (Nasdaq - RPHM)

June 25, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AAN, RPHM on Behalf of Shareholders

June 21, 2024

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SBOW, PRFT, RPHM on Behalf of Shareholders

June 18, 2024

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avangrid, Inc. (NYSE - AGR), SilverBow Resources, Inc. (NYSE - SBOW), Reneo Pharmaceuticals, Inc. (Nasdaq - RPHM), Perficient, Inc. (Nasdaq - PRFT)

June 18, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BATL, DRQ, RPHM, PRFT on Behalf of Shareholders

June 14, 2024

From Halper Sadeh LLC

Via GlobeNewswire

June 07, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avangrid, Inc. (NYSE – AGR), SilverBow Resources, Inc. (NYSE – SBOW), Reneo Pharmaceuticals, Inc. (Nasdaq – RPHM), Perficient, Inc. (Nasdaq – PRFT)

May 29, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

ALERT: Halper Sadeh LLC Continues to Investigate PRFT, SBOW, RPHM, UNIT; Shareholders are Encouraged to Contact the Firm

May 29, 2024

From Halper Sadeh LLC

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session

May 28, 2024

Via Benzinga

May 20, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Pre-Market Session

May 17, 2024

Via Benzinga

Reneo Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Buying

May 17, 2024

Via Benzinga

RENEO PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHM

May 14, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

What's Going On With Reneo Pharmaceuticals Stock Today?

May 13, 2024

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Reneo Pharmaceuticals, Inc. (Nasdaq – RPHM), ALLETE, Inc. (NYSE – ALE), Perficient, Inc. (Nasdaq – PRFT), Hibbett, Inc. (Nasdaq – HIBB)

May 13, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

RPHM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Reneo Pharmaceuticals, Inc. Is Fair to Shareholders

May 13, 2024

From Halper Sadeh LLC

Via Business Wire

Frequently Asked Questions

Is Reneo Pharmaceuticals, Inc. - Class A Common Stock publicly traded?

Yes, Reneo Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.

What exchange does Reneo Pharmaceuticals, Inc. - Class A Common Stock trade on?

Reneo Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Reneo Pharmaceuticals, Inc. - Class A Common Stock?

The ticker symbol for Reneo Pharmaceuticals, Inc. - Class A Common Stock is RPHM on the Nasdaq Stock Market

What is the current price of Reneo Pharmaceuticals, Inc. - Class A Common Stock?

The current price of Reneo Pharmaceuticals, Inc. - Class A Common Stock is 1.820

When was Reneo Pharmaceuticals, Inc. - Class A Common Stock last traded?

The last trade of Reneo Pharmaceuticals, Inc. - Class A Common Stock was at 10/04/24 04:00 PM ET

What is the market capitalization of Reneo Pharmaceuticals, Inc. - Class A Common Stock?

The market capitalization of Reneo Pharmaceuticals, Inc. - Class A Common Stock is 61.25M

How many shares of Reneo Pharmaceuticals, Inc. - Class A Common Stock are outstanding?

Reneo Pharmaceuticals, Inc. - Class A Common Stock has 61M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.